BioSpace News Archive

Parent company, San Antonio-based ECS Learning Systems, guarantees that their STAAR MASTER solution will improve STAAR outcomes

Announced today the launch of a collaboration to discover and develop novel therapies for cardiac disease and diseases associated with cardiac muscle aging.

Consortium leverages DNAnexus cloud-based platform to scale genome assembly and improve quality for the maize population

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that it has dosed the first adult patient with acute otitis media in a phase 1 clinical trial of OP0201, the company’s lead product candidate being developed for otitis media.

Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has granted it a patent for RTF, its breakthrough “Real-Time Focusing” technology (US patent 9,841,590). T

Global warming is a serious problem, mainly because of the increase in greenhouse gases such as methane and carbon oxide (CO2), as well as society’s dependence on petroleum products.

The decision to implement Jiva 6.1 derived from a need for advanced care management capabilities for BMCHS’ accountable care efforts as part of the Massachusetts Medicaid ACO program.

2018 highlights include expansion to U.S., new partnerships with leading pharmaceutical companies, and growth of diagnostic testing portfolio for rare diseases - driving momentum into 2019

Industry leaders strengthen partnership to meet growing demand for pesticide-free medical cannabis

- Molecular Health Predict enables highly accurate estimates of clinical trial success probabilities - Exclusive license for the financial industry granted to DATEN CAPITAL - Molecular Health to receive an annual license fee and success-based payments